ANNEMARIE ODO: Open Payments
NPI 1083235691 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$739 in 16 payments from 5 companies in 2025. Trend: 2023 $589 · 2024 $2,071 · 2025 $739
Food & beverage: $739
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $214 |
| ABBVIE INC. | 5 | $176 |
| Braeburn Inc. | 2 | $147 |
| Axsome Therapeutics, Inc. | 2 | $112 |
| Otsuka America Pharmaceutical, Inc. | 1 | $90 |
Products named: VRAYLAR, BRIXADI, LYBALVI, Auvelity, REXULTI, VIVITROL, ARISTADA.
Industry payments across TX — which companies pay providers there.
